MedPath

Immunis, Inc.

Immunis, Inc. logo
🇺🇸United States
Ownership
Holding
Established
2018-01-01
Employees
11
Market Cap
-
Website
http://www.immunisbiomedical.com

Clinical Trials

3

Active:1
Completed:0

Trial Phases

2 Phases

Phase 1:1
Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (50.0%)
Phase 2
1 (50.0%)

INTERMEDIATE-SIZE PATIENT POPULATIONS EXPANDED ACCESS to TREATMENT for SARCOPENIC OBESITY

Conditions
Sarcopenia
Obesity and Obesity-related Medical Conditions
First Posted Date
2025-01-20
Last Posted Date
2025-01-21
Lead Sponsor
Immunis, Inc.
Registration Number
NCT06784297

Safety and Efficacy of IMM01-STEM Against Placebo on Muscle Performance in Seniors With Obesity and Muscle Weakness

Phase 2
Recruiting
Conditions
Muscle Performance
Sarcopenic Obesity
Interventions
Other: Placebo
Biological: IMM01-STEM alternating with placebo (saline)
First Posted Date
2024-09-19
Last Posted Date
2025-05-16
Lead Sponsor
Immunis, Inc.
Target Recruit Count
55
Registration Number
NCT06600581
Locations
🇺🇸

National Institute of Clinical Research (NICR), Pomona, California, United States

🇺🇸

Johnson Country Clinical Trials (JCCT), Lenexa, Kansas, United States

🇺🇸

Tekton Research, Wichita, Kansas, United States

Safety and Tolerability of IMM01-STEM in Patients With Muscle Atrophy Related to Knee Osteoarthritis.

Phase 1
Active, not recruiting
Conditions
Muscle Atrophy
Interventions
First Posted Date
2022-01-27
Last Posted Date
2025-07-01
Lead Sponsor
Immunis, Inc.
Target Recruit Count
28
Registration Number
NCT05211986
Locations
🇺🇸

Orthopaedic Specialty Institute, Irvine, California, United States

🇺🇸

University of California, Irvine - Alpha Stem Cell Clinic, Orange, California, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.